Allman, J., McLaughlin, T. & Hakeem, A. (1993) Brain structures and life-span in primate species. Proceedings of the National Academy of Sciences USA, 90, 3559–3563.
Barnes, T. R. E. (1990) Comment on the WHO consensus statement, British Journal of Psychiatry, 156, 413–414.
Brown, S. (1997) Excess mortality of schizophrenia. A meta-analysis, British Journal of Psychiatry, 171, 502–508.
Caldwell, C. B. & Gottesman, I. I. (1990) Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophrenia Bulletin, 16, 571–589.
Department of Health (1995) Health Statistics 1993. Dublin: Stationery Office. Government of Ireland.
Dufresne, R. L. (1995) Psychiatric pharmacy research workshop: Issues in polypharmacotherapy. Psychopharmacology Bulletin, 31, 789–796.
Jablensky, A. (1995) Schizophrenia: the epidemiological horizon. In Schizophrenia (eds Hirsch, S. R. & Weinberger, D. R.), pp. 206–252. Oxford: Blackwell.
Joseph, K. S., Blais, L., Ernst, P., et al (1996) Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. British Medical Journal, 312, 79–83.
Kane, J. M. (1995) Psychopharmacological approaches to schizophrenia: practical aspects. In Advances in the Neurobiology of Schizophrenia (eds Den Boer, J. A., Westenberg, H. G. M. & Van Praag, H. M.). pp. 245–263. Chichester: Wiley.
Kane, J. M. (1996) Drug therapy: schizophrenia. New England Journal of Medicine, 334, 34–41.
Licht, R. W., Mortensen, P. B., Gouliaev, G., et al (1993) Mortality in Danish psychiatric long-stay patients. 1972–1982. Acta Psychiatrica Scandinavica, 87, 336–341.
McKeith, I., Fairbairn, A., Perry, R., et al (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type, british Medical Journal, 305, 673–678.
Naftdowitz, D. F., Donovan, S. & Frances, A. (1995) The new polypharmacy in psychiatry: clinical practice and clinical research part company. CNS Drugs, 4, 404–409.
Rakowski, W. & Mor, V. (1992) The association of physical activity with mortality among older adults in the longitudinal study of aging (1984–1988). Journal of Gerontology, 47, M122–M129.
Saku, M., Tokudome, S., Ikeda, M., et al (1995) Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. International Journal of Epidemiology, 24, 366–372.
Stones, M. J., Doman, B. & Kozma, A. (1989) The prediction of mortality in elderly institution residents. Journal of Gerontology, 44, P72–P79.
Waddington, J. L. (1992) Mechanisms of neuroleptic -induced extrapyramidal side effects. In Adverse Effects of Psychotropic Drugs (eds Kane, J. M. & Lieberman, J. A.), pp. 246–265. New York: Guilford Press.
Waddington, J. L. (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet, 341, 531–536.
Waddington, J. L. (1995) The clinical psychopharmacology of antipsychotic drugs in schizophrenia. In Schizophrenia (eds Hirsch, S. R. & Weinberger, D. R.), pp. 341–357. Oxford: Blackwell.
Waddington, J. L., Youssef, H. A., Dolphin, C., et al (1987) Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Archives of General Psychiatry, 44, 907–912.
Waddington, J. L., Youssef, H. A., & Kinsella, A. (1990) Cognitive dysfunction in schizophrenia followed up over five years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine, 20, 835–842.
Waddington, J. L., Youssef, H. A., & Kinsella, A. (1995) Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine, 25, 849–857.
Weinberger, D. R. (1995) Schizophrenia: from neuropathology to neurodevelopment. Lancet, 346, 552–557.
Working Group of the Royal College of Psychiatrists, Psychopharmacology Sub-Group (1997) The Association between Antipsychotic Drugs and Sudden Death. Council Report CR57. London: Royal College of Psychiatrists.
World Health Organization (1978) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. (ICD-9). Geneva: WHO.
World Health Organization Heads of Centres Collaborating in WHO Coordinated Studies on Biological Aspects of Mental Illness (1990) Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement, british Journal of Psychiatry, 156, 412.
Yoneyama, T., Hashimoto, K., Fukuda, H., et al (1996) Oral hygiene reduces respiratory infections in elderly bed-bound nursing home patients. Archives of Gerontology and Geriatrics, 22, 11–19.